Enhancement of fracture healing in the rat, modulated by compounds that stimulate inducible nitric oxide synthase

Bone and Joint Research - Tập 6 Số 2 - Trang 90-97 - 2017
Rebecca Rajfer1, A. Kılıç2, Andrew S. Neviaser1, Leah M. Schulte1, Su M Hlaing3, Jose Landeros3, Mónica G. Ferrini3, Edward Ebramzadeh4, So Hyun Park4
1Department of Orthopaedic Surgery, George Washington University, Washington, DC, USA
2Department of Orthopaedics, School of Medicine, Bahcesehir University, Istanbul, Turkey.
3Department of Health and Life Sciences, College of Science and Health, Charles Drew University of Medicine and Science, Los Angeles, California, USA
4Department of Orthopaedic Surgery, The J. Vernon Luck, Sr., M.D. Orthopaedic Research Center, Orthopaedic Institute for Children, University of California, Los Angeles, California, USA

Tóm tắt

Objectives

We investigated the effects on fracture healing of two up-regulators of inducible nitric oxide synthase (iNOS) in a rat model of an open femoral osteotomy: tadalafil, a phosphodiesterase inhibitor, and the recently reported nutraceutical, COMB-4 (consisting of L-citrulline, Paullinia cupana, ginger and muira puama), given orally for either 14 or 42 days.

Materials and Methods

Unilateral femoral osteotomies were created in 58 male rats and fixed with an intramedullary compression nail. Rats were treated daily either with vehicle, tadalafil or COMB-4. Biomechanical testing of the healed fracture was performed on day 42. The volume, mineral content and bone density of the callus were measured by quantitative CT on days 14 and 42. Expression of iNOS was measured by immunohistochemistry.

Results

When compared with the control group, the COMB-4 group exhibited 46% higher maximum strength (t-test, p = 0.029) and 92% higher stiffness (t-test, p = 0.023), but no significant changes were observed in the tadalafil group. At days 14 and 42, there was no significant difference between the three groups with respect to callus volume, mineral content and bone density. Expression of iNOS at day 14 was significantly higher in the COMB-4 group which, as expected, had returned to baseline levels at day 42.

Conclusion

This study demonstrates an enhancement in fracture healing by an oral natural product known to augment iNOS expression. Cite this article: R. A. Rajfer, A. Kilic, A. S. Neviaser, L. M. Schulte, S. M. Hlaing, J. Landeros, M. G. Ferrini, E. Ebramzadeh, S-H. Park. Enhancement of fracture healing in the rat, modulated by compounds that stimulate inducible nitric oxide synthase: Acceleration of fracture healing via inducible nitric oxide synthase. Bone Joint Res 2017:6:–97. DOI: 10.1302/2046-3758.62.BJR-2016-0164.R2.

Từ khóa


Tài liệu tham khảo

Caplan AI, 1990, Clin Orthop Relat Res, 257

10.1016/S8756-3282(01)00608-1

10.1016/S0020-1383(08)70015-9

10.1016/S0014-5793(97)00597-8

Baldik Y, Clin Orthop Relat Res, 2002, 343

10.1080/10715769900301161

10.1016/0006-2952(95)00181-6

10.1302/0301-620X.81B3.0810531

10.1359/jbmr.2000.15.2.342

10.1359/jbmr.2002.17.8.1470

10.1210/endo.136.12.7588294

10.1111/j.1749-6632.2009.05230.x

10.1016/j.bone.2004.10.002

Katsuki S, 1977, J Cyclic Nucleotide Res, 3, 23

10.1073/pnas.74.8.3203

Weiss B, 1975, Adv Cyclic Nucleotide Res, 5, 195

10.1002/jor.21324

10.5606/ehc.2015.29

10.4172/2167-0250.1000132

10.1016/j.bone.2011.07.007

10.1096/fj.07-9574LSF

10.2106/00004623-200308000-00004

10.2106/00004623-199806000-00011

10.2106/00004623-197759020-00009

Klein-Nulend J, 2014, Osteoporos Int, 25, 1427

10.1023/A:1005940202801

10.1002/(SICI)1097-0347(200001)22:1<71::AID-HED11>3.0.CO;2-G

10.1006/niox.2001.0421

10.1359/jbmr.2002.17.6.1015

Fox SW, 1996, Am J Physiol, 270, E955

10.1161/01.RES.68.3.756

10.1359/jbmr.2002.17.2.249

Kovanecz I, 2008, BJU Int, 101, 203, 10.1111/j.1464-410X.2007.07223.x

No authors listed. Highlight of prescribing information. http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021368s011lbl.pdf (date last accessed 01 December 2016).

Henrie AM, 2015, Core Evid, 10, 99

10.1097/00005131-199902000-00008

10.1302/0301-620X.84B8.0841093

Gruenwald J. PDR for Herbal Medicines 2nd ed. Montvale, New Jersey Thompson: Medical Economics Co 2000:531-532.

10.1002/ptr.1484